Page last updated: 2024-11-08

4-nitroquinoline-1-oxide and Glioblastoma

4-nitroquinoline-1-oxide has been researched along with Glioblastoma in 1 studies

4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research Excerpts

ExcerptRelevanceReference
" Neurogenic A172, U251, and SH-SY5Y cells were intermittently (5 min on/10 min off) exposed to 1800 MHz RF-EMF at an average specific absorption rate (SAR) of 4."1.46RF-EMF exposure at 1800 MHz did not elicit DNA damage or abnormal cellular behaviors in different neurogenic cells. ( Chen, G; Su, L; Wei, X; Xu, Z, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, L1
Wei, X1
Xu, Z1
Chen, G1

Other Studies

1 other study available for 4-nitroquinoline-1-oxide and Glioblastoma

ArticleYear
RF-EMF exposure at 1800 MHz did not elicit DNA damage or abnormal cellular behaviors in different neurogenic cells.
    Bioelectromagnetics, 2017, Volume: 38, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; DNA Damage; Elec

2017